STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		107 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
Cash flows from operating activities
Net loss	$ (5,968,448)	$ (5,469,067)	$ (100,680,787)
Adjustments to reconcile net loss to net cash used in operating activities
Stock payable for acquired research and development			112,440
Stock issued for acquired research and development			26,286,589
Stock issued for services	87,028	64,350	2,061,743
Stock issued for debt in excess of principal			109,070
Amortization of discount on notes payable due to warrants and beneficial conversion feature		314,749	6,752,698
Gain on extinguishment of debt			(1,612,440)
Depreciation	210,252	168,843	1,346,481
Amortization of debt financing costs		108,117	524,378
Option and warrant expense	489,914	508,550	15,575,207
Loss (gain) on derivative instruments			(1,388,848)
Loss on disposal of fixed assets	9,686	459	510,248
Changes in:
Accounts receivable	26,245	(26,245)
Prepaid and other expenses	(65,493)	19,909	(541,446)
Accounts payable - third parties and related parties	(13,028)	(251,765)	(89,241)
Accrued expenses	234,923	186,087	522,220
Net cash used in operating activities	(4,988,921)	(4,376,013)	(50,511,688)
Cash flows from investing activities
Purchase of property & equipment	(296,949)	(35,350)	(1,671,810)
Net cash used in investing activities	(296,949)	(35,350)	(1,671,810)
Cash flows from financing activities
Common stock and warrants sold for cash, net of offering costs	8,618,157		49,072,488
Common stock repurchased and canceled			(325)
Proceeds from exercise of warrants and options		109,641	1,248,588
Proceeds from debt			9,283,184
Repayments on loan payable	(35,607)	(67,325)	(311,222)
Net cash provided by financing activities	8,582,550	42,316	59,292,713
Net change in cash and cash equivalents	3,296,680	(4,369,047)	7,109,215
Cash and cash equivalents at beginning of period	3,812,535	8,181,582
Cash and cash equivalents at end of period	7,109,215	3,812,535	7,109,215
Cash paid for:
Income tax
Interest	3,135	86,491	153,163
NON-CASH TRANSACTIONS
Issuance of common stock to Sportan shareholders			147,733
Issuance of common stock for accrued interest		78,091	603,604
Issuance of warrants to placement agent			37,453
Conversion of notes payable to common stock		1,302,000	7,709,980
Conversion of accrued liabilities to common stock			197,176
Conversion of accounts payable to note payable			93,364
Discount on convertible notes relating to:
Warrants			3,659,737
Beneficial conversion feature			1,805,519
Stock attached to notes			1,287,440
Fair value of derivative instrument			4,680,220
Derivative reclassified to equity			587,609
Unpaid additions to property and equipment	$ 136,266		$ 136,266